EOLS
Evolus, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +6.0% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 63 | +6 | 23.25M | $161.16M | +10 | −4 |
| Q1 2026 | 59 | -7 | 18.93M | $77.97M | +3 | −10 |
| Q4 2025 | 66 | -1 | 24.04M | $159.85M | — | −1 |
| Q3 2025 | 17 | -1 | 17.27M | $106.03M | — | −1 |
| Q2 2025 | 15 | 0 | 14.12M | $130.04M | +1 | −1 |
| Q1 2025 | 12 | +2 | 7.19M | $86.49M | +2 | — |
| Q4 2024 | 10 | -1 | 6.42M | $70.90M | — | −1 |
| Q3 2024 | 10 | 0 | 4.64M | $75.21M | +1 | −1 |
| Q2 2024 | 10 | — | 4.38M | $47.51M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 1.21M | +0.9% | $19.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.21M | +0.9% | $19.62M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Millennium Management ✦ | 1.03M | +14.5% | $16.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 970.27K | +11.4% | $15.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 970.27K | +11.4% | $15.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Soros Fund Management ✦ | 850.00K | 0.0% | $13.77M | 0.4% | Held | 2 | SEC ↗ |
| 7 | Wellington Management ✦ | 175.04K | +30.3% | $2.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 175.04K | +30.3% | $2.84M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 151.05K | +135.6% | $2.45M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 149.56K | +107.7% | $2.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 149.56K | +107.7% | $2.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 149.56K | +107.7% | $2.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 52.00K | +27.8% | $842,384 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 46.26K | +1.4% | $750,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 8.13K | New | $131,662 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $131,662 | 0.0% |
Exited
| Marshall Wace | $2.19M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 146 holders, 45.63M shares, $187.01M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.